Genentech Ophthalmology Co-pay Program - Lucentis
Genentech, Inc. (Roche) · Lucentis
Patient pays: as little as $0 per Lucentis co-pay
commercial insurance
Patient assistance
Tell us your insurance and household details. We’ll show you every Lucentis assistance program you may qualify for - the real manufacturer and foundation programs, not a discount card - with sources and a direct link to apply. About a minute, no login.
Lucentis help that still works on Medicare or Medicaid - the programs copay cards leave out.
Lucentis (ranibizumab) is an anti-vegf (intravitreal) made by Roche / Genentech (US) / Novartis (ex-US). It is commonly prescribed for: Neovascular (wet) age-related macular degeneration, Diabetic macular edema, Diabetic retinopathy, Macular edema following retinal vein occlusion, Myopic choroidal neovascularization.
Tell us five things. We’ll do the rest.
Reference
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Genentech, Inc. (Roche) · Lucentis
Patient pays: as little as $0 per Lucentis co-pay
commercial insurance
Genentech, Inc. (Roche) · Lucentis
uninsured · underinsured
Common questions